Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRxSight Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.38 | -$0.24 | -$0.30 |
| Q2 2026 | 3 | -$0.42 | -$0.27 | -$0.33 |
| Q3 2026 | 3 | -$0.35 | -$0.18 | -$0.27 |
| Q4 2026 | 3 | -$0.10 | -$0.07 | -$0.09 |
| Q1 2027 | 1 | -$0.40 | -$0.25 | -$0.31 |
| Q2 2027 | 1 | -$0.37 | -$0.24 | -$0.29 |
| Q3 2027 | 1 | -$0.37 | -$0.23 | -$0.29 |
| Q4 2027 | 1 | -$0.38 | -$0.24 | -$0.30 |
| Q1 2028 | 2 | -$0.27 | -$0.17 | -$0.21 |
| Q2 2028 | 2 | -$0.28 | -$0.18 | -$0.22 |
| Q3 2028 | 2 | -$0.27 | -$0.17 | -$0.21 |
| Q4 2028 | 2 | -$0.28 | -$0.18 | -$0.22 |
RxSight Inc Earnings Date And Information
RxSight Inc last posted its earnings results on Wednesday, August 5th, 2026. The company reported $-0.29 earnings per share for the quarter, topping analysts' consensus estimates of $-0.32937 by $0.03937. The company had revenue of 33.74 M for the quarter and had revenue of 134.48 M for the year. RxSight Inc has generated $-1 earnings per share over the last year ($-0.95 diluted earnings per share) and currently has a price-to-earnings ratio of -5.38. RxSight Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
RxSight Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2026 | Q2 2026 | -$0.33 | -$0.29 | 0.04 | $32.55 M | $33.74 M |
| 05/06/2026 | Q1 2026 | -$0.30 | -$0.38 | -0.08 | $29.75 M | $30.89 M |
| 02/25/2026 | Q4 2025 | -$0.33 | -$0.22 | 0.11 | $30.17 M | $32.61 M |
| 11/05/2025 | Q3 2025 | -$0.19 | -$0.24 | -0.05 | $25.28 M | $30.34 M |
| 08/07/2025 | Q2 2025 | -$0.10 | -$0.29 | -0.19 | $34.79 M | $33.64 M |
| 05/07/2025 | Q1 2025 | -$0.22 | -$0.20 | 0.02 | $38.08 M | $37.90 M |
| 02/25/2025 | Q4 2024 | $0.10 | -$0.15 | -0.25 | $40.31 M | $40.21 M |
| 11/07/2024 | Q3 2024 | -$0.25 | -$0.16 | 0.09 | $35.06 M | $45.41 M |
| 08/05/2024 | Q2 2024 | -$0.22 | -$0.16 | 0.06 | $32.33 M | $34.89 M |
| 05/06/2024 | Q1 2024 | -$0.17 | -$0.25 | -0.08 | $27.56 M | $29.51 M |
| 12/29/2023 | Q4 2023 | N/A | -$0.26 | N/A | $28.25 M | $28.58 M |
| 11/09/2023 | Q3 2023 | -$0.42 | -$0.35 | 0.07 | $20.55 M | $30.67 M |
| 08/07/2023 | Q2 2023 | -$0.47 | -$0.40 | 0.07 | $19.23 M | $20.81 M |
| 05/09/2023 | Q1 2023 | -$0.52 | -$0.47 | 0.05 | $16.28 M | $17.49 M |
| 03/06/2023 | Q4 2022 | -$0.72 | -$0.56 | 0.16 | $15.85 M | $16.09 M |
| 11/07/2022 | Q3 2022 | -$0.70 | -$0.61 | 0.09 | $10.98 M | $12.62 M |
| 08/08/2022 | Q2 2022 | -$0.68 | -$0.61 | 0.07 | $10.55 M | $11.36 M |
| 05/05/2022 | Q1 2022 | -$0.56 | -$0.64 | -0.08 | $7.32 M | $8.94 M |
| 03/08/2022 | Q4 2021 | -$0.58 | -$0.58 | 0 | $7.64 M | $8.43 M |
| 11/10/2021 | Q3 2021 | -$0.61 | -$0.68 | -0.07 | $5.22 M | $5.79 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
RxSight Inc Earnings: FAQ's
In the previous quarter, RxSight Inc (:RXST) reported $-0.29 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.32937 by $0.03937.
The conference call for RxSight Inc's latest earnings report can be listened to online.
The conference call transcript for RxSight Inc's latest earnings report can be read online.
RxSight Inc (:RXST) has a recorded annual revenue of $134.48 M.
RxSight Inc (:RXST) has a recorded net income of $-38,943,000.RxSight Inc has generated $-0.95 earnings per share over the last four quarters.
RxSight Inc (:RXST) has a price-to-earnings ratio of -5.38 and price/earnings-to-growth ratio is 0.16.